Latest news
Nuvation Bio (NUVB) Stock Rises On IBTROZI Growth And Deeper Losses - simplywall.stsimplywall.st · Sat, 08 Aug 2026 03:40:16 GMTA Quick Look at Today's Ratings for Nuvation Bio(NUVB.US), With a Forecast Between $12 to $21 - MoomooMoomoo · Fri, 07 Aug 2026 19:48:22 GMTNUVB Stock Is Soaring Today — Why RBC Sees $3B Opportunity In Nuvation Bio's Brain Cancer Drug - StocktwitsStocktwits · Fri, 07 Aug 2026 15:55:52 GMTB. Riley Adjusts Price Target on Nuvation Bio to $15 From $12, Maintains Buy Rating - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 14:19:35 GMTWhy Nuvation Bio (NUVB) Is Down 8.8% After Surging Q2 2026 Revenue and IBTROZI Data Tease - simplywall.stsimplywall.st · Fri, 07 Aug 2026 12:39:50 GMTNUVB SWOT Analysis: Revenue Surge Amidst Ongoing Losses Revealed in 10-Q Filing - GuruFocusGuruFocus · Fri, 07 Aug 2026 09:26:46 GMTNuvation Bio (NYSE:NUVB) Announces Quarterly Earnings Results - MarketBeatMarketBeat · Fri, 07 Aug 2026 02:50:37 GMTNuvation Bio reports $31.7M Q2 revenue, IBTROZI... - PluangPluang · Thu, 06 Aug 2026 21:00:16 GMT